Verastem (VSTM) Profit After Tax Growth (3y) (2014 - 2026)
Powered by 
Analysis
Verastem (VSTM) Profit After Tax Growth (3y) (2014 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | PAT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 6.30% |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 10.23% |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 91.31% |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 17.25% |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 37.89% |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 37.44% |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | -38.56% |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 59.34% |
| 10 | Verastem | 814.94 Mn | 678.59 Mn | 36.32 Mn | -13.23% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -13.23% |
| Mar 31, 2026 | -32.54% |
| Dec 31, 2025 | -21.89% |
| Sep 30, 2025 | -75.94% |
| Jun 30, 2025 | -5.71% |
| Mar 31, 2025 | -45.37% |
| Dec 31, 2024 | -57.65% |
| Sep 30, 2024 | -1.68% |
| Jun 30, 2024 | 21.25% |
| Mar 31, 2024 | -31.09% |
| Dec 31, 2023 | -11.27% |
| Sep 30, 2023 | -52.16% |
| Jun 30, 2023 | -1.81% |
| Mar 31, 2023 | 25.49% |
| Dec 31, 2022 | 24.38% |
| Sep 30, 2022 | 15.65% |
| Jun 30, 2022 | 19.57% |
| Mar 31, 2022 | 23.64% |
| Dec 31, 2021 | -13.23% |
| Sep 30, 2021 | -1.71% |